Vyacheslav V. Vostrikov

Vyacheslav V. Vostrikov

Auto-generated profile, based on publicly available information

Vyacheslav V. Vostrikov

Altai State Medical University, Barnaul, Russia

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 December 2017 in Obesity and metabolism
Verified
Journal Article
Open access
PDF file
TZTamara V. Zhuk
Tamara V. Zhuk
SYSvetlana D. Yavorskaya
Svetlana D. Yavorskaya
VVVjacheslav V. Vostrikov
Vjacheslav V. Vostrikov
The prevalence of obesity and overweight is one of the most pressing problems nowadays. Obesity as a comorbid condition affects all body systems. Obesity has been reported to be a risk factor not only for cardiovascular diseases and oncopathology, but also for fertility problems, many obstetric and perinatal complications worsening the maternal and infant health. The balance between the oxidative and antioxidant system is one of the indicators of the state of human homeostasis. Today it is proved that obesity is associated with an increase in oxidative stress and a decrease in antioxidant protection. This review reveals a close relationship between obesity, oxidative stress and reproductive problems.

30 December 2024 in Dalʹnevostočnyj medicinskij žurnal
Verified
Journal Article
Closed access
KDKsenia Vl. Dmitrienko
Ksenia Vl. Dmitrienko
SYSvetlana Dm. Yavorskaya
Svetlana Dm. Yavorskaya
VVVуacheslav V. Vosrtikov
Vуacheslav V. Vosrtikov
TGTatiana Iv. Gorbacheva
Tatiana Iv. Gorbacheva

30 December 2024 in Dalʹnevostočnyj medicinskij žurnal
Verified
Journal Article
Closed access
KDKsenia Vl. Dmitrienko
Ksenia Vl. Dmitrienko
SYSvetlana Dm. Yavorskaya
Svetlana Dm. Yavorskaya
VVVуacheslav V. Vosrtikov
Vуacheslav V. Vosrtikov
TGTatiana Iv. Gorbacheva
Tatiana Iv. Gorbacheva

1 January 2026 in Bulletin of Medical Science
Verified
Journal Article
Open access
AKAleksey V. Kukhlenko
Aleksey V. Kukhlenko
ECElena P. Chelusheva
Elena P. Chelusheva
IZIrina V. Zhukova
Irina V. Zhukova
VVVyacheslav V. Vostrikov
Vyacheslav V. Vostrikov
The Altai Republic has 111,552 female population, of which 51,313 are of reproductive age. At the beginning of 2025, 266 women were under dispensary supervision with a diagnosis of ‘female infertility’, the frequency of which has increased by 25.5% over the past five years. Objective. To study the ovarian reserve and identify the effectiveness of IVF programs in women – residents of the Altai Republic with endocrine infertility, taking into account the place of residence. Materials and Methods. The study included 800 patients with endocrine infertility who were referred to assisted reproductive technology (ART) programs over a 5-year period (2021–2025), of which 17.1% had low levels of AMH. To analyze the ovarian reserve index (AMH level) and the effectiveness of IVF programs, women were divided into groups based on their place of residence (city/village) and the age of the procedure. Results. In a comparative analysis over the past 5 years, there has been a decrease in the number of city dwellers who undergo IVF with low AMH levels from 60.0% to 34.4%, and an increase in the number of rural dwellers with low AMH levels from 40.0% to 65.6% (R2 = 0,961) (p < 0.001). During a 5-year period, there was a trend towards a decrease in the number of positive outcomes of IVF programs, from 33.3% in 2021 to 11.5% in 2024, with no positive results in 2025 (n = 17), indicating a continuing decline in reproductive health, including low ovarian reserve. Conclusions. Age, location, and AMH levels are significant predictors of individual ovarian reserve and should be considered when predicting the effectiveness of IVF programs.

1 January 2024 in Bulletin of Medical Science
Verified
Journal Article
Open access
VVViacheslav V. Vostrikov
Viacheslav V. Vostrikov
AUAltai State Medical University
Altai State Medical University
МНМария Геннадьевна Николаева
Мария Геннадьевна Николаева
IMIrina V. Molchanova
Irina V. Molchanova
NFNatalia I. Fadeeva
Natalia I. Fadeeva
ADAltai Regional Clinical Perinatal Center Dar
Altai Regional Clinical Perinatal Center Dar
Objectives. This study aimed to clarify the role of intrauterine insemination (IUI) within the clinical practice of a regional infertility center. Methods. A retrospective, single-center, non-randomized study was conducted on 1934 women with infertility who sought evaluation and treatment at the regional infertility center between April 28, 2001, and December 31, 2021. This study involved a comparative analysis of patients undergoing IUI with either partner sperm or donor sperm. Various factors such as age, ovarian stimulation, number of mature follicles (IUI multiplicity), and duration of treatment were examined to assess their impact on the outcomes of infertility treatment. Results. The study revealed a decrease in the success rates of intrauterine inseminations using partner sperm in women aged 36 and older, with a success rate of 5.1% to 8.9% (p=0.027) compared to patients aged 30-35. Conversely, when using donor sperm for IUI, the pregnancy rate was higher in women under 30 years of age, at 16.9% versus 7.6% in women aged 36 and older (p=0.0001). Furthermore, the study found no significant advantage of using IUI in cases of infertility with unspecified causes. Conclusion. Intrauterine insemination (IUI) can be an effective treatment for infertility under specific circumstances, such as when the male partner is absent, experiences erectile dysfunction, or has secretory azoospermia. However, the study highlights that ovulation stimulation prior to IUI and performing multiple inseminations in a single cycle for women with regular ovulatory cycles do not necessarily improve treatment outcomes.

25 December 2025 in Russian Journal of Human Reproduction
Verified
Journal Article
Closed access
VVV.V. Vostrikov
V.V. Vostrikov
VZV.M. Zdanovsky
V.M. Zdanovsky
ESE.A. Subbotin
E.A. Subbotin
The aim of the study. To study the incidence of polycystic ovary syndrome (PCOS) in the clinical practice of a regional infertility treatment center, to perform a comparative analysis of the clinical characteristics of PCOS phenotypes, and to evaluate the results of fertility restoration depending on the phenotype and treatment tactics. Material and methods. The retrospective, single-center, non-randomized study included 1.273 women with ovulation disorders who sought help from a regional infertility diagnostic and treatment center from April 27, 2001, to December 31, 2021. We excluded 297 (23.3%) patients who did not undergo adequate examination and 237 (18.6%) women with combined forms of infertility. Women were divided into 4 types depending on the causes of anovulation according to the FIGO classification: I — anovulation due to hypothalamic pathology (n=32, 4.2%); Type II — anovulation due to pituitary disorders (n=59, 7.7%); Type III — ovarian anovulation (n=118, 15.5%); Type IV — PCOS (n=530, 71.7%). Women classified as PCOS were divided according to the Rotterdam Consensus based on phenotypes. A comparative assessment of the clinical characteristics of the PCOS phenotypes was performed. Reproductive function was monitored depending on the chosen treatment strategy and phenotype. Results. Pregnancy occurred in 317 (59.8%) of 530 women with PCOS. The effectiveness of patient management models, from expectant management to the use of assisted reproductive technologies (ART), was determined. During the correction of endocrine-metabolic disorders, pregnancy occurred in 38 (26.4%) of 144 women, after ovulation stimulation — in 104 of 337 (30.9%). Endoscopic ovarian drilling contributed to pregnancy in 48 (47.5%) of 101 women. The overall pregnancy rate without the use of ART was 47.2%. A failed pregnancy within 6-8 months, despite the restoration of ovulation, served as a basis for in vitro fertilization, the pregnancy rate was 57.1%. Intrauterine insemination for endocrine infertility had the lowest success rate—pregnancy occurred in 7 (11.7%) of 60 women. Conclusion. The frequency of polycystic ovary syndrome diagnosis in women seeking treatment at a regional infertility center is consistent with rates in other regions of Russia and internationally. Comprehensive treatment of endocrine and metabolic disorders can be considered as a standalone treatment method, as well as preparation for the next stages of infertility management. Ovulation stimulation is the next step after correction of endocrine and metabolic disorders. Ovarian drilling is a backup method for restoring ovulation. If pregnancy has not occurred within 6—8 months, assisted reproductive technologies are indicated.